CryoPort Inc. (CYRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for CryoPort Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$18.64
+1.25% today
Market cap
$932M
Overall quality
43/100
Kronos AI 30-day
−18.0%
0 of 8 simulated paths end higher
CryoPort Inc. (CYRX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $932M. It trades at $18.64, up 1.25% today. Its overall quality score is 43 out of 100, ranked against the whole US market. 5 analysts' average target of $21.00 implies +12.7% from today's price. Kronos AI's 30-day forecast is −18.0% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $21.00 |
| Low – high | $19.00 – $26.00 |
| Analysts | 5 |
| Upside to average | +12.7% |
Kronos AI 30-day forecast
| Expected close | $15.09 (−18.0%) |
| Likely range | −23.0% … −14.1% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 26 |
| Solvency | 50 |
| Growth | 54 |
| Overall | 43 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.